These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27742115)

  • 1. Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles.
    Mehta A; Ghaghada K; Mukundan S
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):751-763. PubMed ID: 27742115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal contrast agents in brain tumor imaging.
    Ghaghada KB; Colen RR; Hawley CR; Patel N; Mukundan S
    Neuroimaging Clin N Am; 2010 Aug; 20(3):367-78. PubMed ID: 20708552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis in Adult Brain Tumors.
    Barajas RF; Cha S
    Neuroimaging Clin N Am; 2016 Nov; 26(4):601-620. PubMed ID: 27712796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of avidin-induced clearance of biotinylated bimodal liposomes for improved MR molecular imaging.
    van Tilborg GA; Strijkers GJ; Pouget EM; Reutelingsperger CP; Sommerdijk NA; Nicolay K; Mulder WJ
    Magn Reson Med; 2008 Dec; 60(6):1444-56. PubMed ID: 19025910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extra-axial brain tumors].
    Papanagiotou P; Ketter R; Reith W
    Radiologe; 2012 Dec; 52(12):1129-46. PubMed ID: 23178788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation.
    Toy R; Hayden E; Camann A; Berman Z; Vicente P; Tran E; Meyers J; Pansky J; Peiris PM; Wu H; Exner A; Wilson D; Ghaghada KB; Karathanasis E
    ACS Nano; 2013 Apr; 7(4):3118-29. PubMed ID: 23464827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast enhancement in primary tumors of the brain and spinal cord.
    Castillo M
    Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted magnetic nanoparticles used as probe for magnetic resonance molecular imaging of tumor].
    Lu JJ; Wang F; Jin ZY; Zhong DR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):124-8. PubMed ID: 19507586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular body imaging: MR imaging, CT, and US. Part II. Applications.
    Kircher MF; Willmann JK
    Radiology; 2012 Aug; 264(2):349-68. PubMed ID: 22821695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast issues in brain tumor imaging.
    Abdullah ND; Mathews VP
    Neuroimaging Clin N Am; 1999 Nov; 9(4):733-49. PubMed ID: 10517942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT and MRI of brain tumors.
    Bruzzone MG; D'Incerti L; Farina LL; Cuccarini V; Finocchiaro G
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):112-37. PubMed ID: 22617235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
    Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
    Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Glucose-Enhanced MR Imaging.
    Paech D; Radbruch A
    Magn Reson Imaging Clin N Am; 2021 Feb; 29(1):77-81. PubMed ID: 33237017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
    Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticles as multimodality imaging agents for brain gliomas.
    Lai SF; Ko BH; Chien CC; Chang CJ; Yang SM; Chen HH; Petibois C; Hueng DY; Ka SM; Chen A; Margaritondo G; Hwu Y
    J Nanobiotechnology; 2015 Nov; 13():85. PubMed ID: 26589283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular body imaging: MR imaging, CT, and US. part I. principles.
    Kircher MF; Willmann JK
    Radiology; 2012 Jun; 263(3):633-43. PubMed ID: 22623690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science to practice: will contrast agents for molecular imaging of angiogenesis help overcome the limitations of functional vascular imaging?
    Kiessling F
    Radiology; 2013 Aug; 268(2):309-11. PubMed ID: 23882090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.